Broadly Neutralizing Antibodies for HIV-1 Prevention by Stephen R. Walsh, Michael S. Seaman

Get full text

Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data. by Andrew L Ferguson, Emilia Falkowska, Laura M Walker, Michael S Seaman, Dennis R Burton, Arup K Chakraborty

Get full text

Rational Design and In Vivo Characterization of mRNA-Encoded Broadly Neutralizing Antibody Combinations against HIV-1 by Elisabeth Narayanan, Samantha Falcone, Sayda M. Elbashir, Husain Attarwala, Kimberly Hassett, Michael S. Seaman, Andrea Carfi, Sunny Himansu

Get full text

Circularized Nanodiscs for Multivalent Mosaic Display of SARS-CoV-2 Spike Protein Antigens by Moustafa T. Mabrouk, Asmaa A. Zidan, Nihal Aly, Mostafa T. Mohammed, Fadi Ghantous, Michael S. Seaman, Jonathan F. Lovell, Mahmoud L. Nasr

Get full text

Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes. by Catarina E Hioe, Terri Wrin, Michael S Seaman, Xuesong Yu, Blake Wood, Steve Self, Constance Williams, Miroslaw K Gorny, Susan Zolla-Pazner

Get full text

Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B viruses. by Hugo Mouquet, Florian Klein, Johannes F Scheid, Malte Warncke, John Pietzsch, Thiago Y K Oliveira, Klara Velinzon, Michael S Seaman, Michel C Nussenzweig

Get full text

Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes. by Geoffrey O Gillard, Maytal Bivas-Benita, Avi-Hai Hovav, Lauren E Grandpre, Michael W Panas, Michael S Seaman, Barton F Haynes, Norman L Letvin

Get full text

Characterization of neutralizing profiles in HIV-1 infected patients from whom the HJ16, HGN194 and HK20 mAbs were obtained. by Sunita S Balla-Jhagjhoorsingh, Betty Willems, Liesbeth Heyndrickx, Leo Heyndrickx, Katleen Vereecken, Wouter Janssens, Michael S Seaman, Davide Corti, Antonio Lanzavecchia, David Davis, Guido Vanham

Get full text

Correction: Thy1 Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive Lymphocytes. by Geoffrey O. Gillard, Maytal Bivas-Benita, Avi-Hai Hovav, Lauren E. Grandpre, Michael W. Panas, Michael S. Seaman, Barton F. Haynes, Norman L. Letvin

Get full text

Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadth by Deniz Cizmeci, Giuseppe Lofano, Evan Rossignol, Anne-Sophie Dugast, Dongkyoon Kim, Guy Cavet, Ngan Nguyen, Yann Chong Tan, Michael S Seaman, Galit Alter, Boris Julg

Get full text

10E8V2.0/iMab: an engineered membrane-anchored bispecific anti-HIV antibody effective in preventing and treating HIV in humanized mice by Anastasia Lanzi, Yaoxing Huang, Jian Yu, Xin Yao, Chasity D. Andrews, Lily Tsai, Mili R. Gajjar, Michael S. Seaman, Neal N. Padte, David D. Ho

Get full text

Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies by Haoqing Wang, Harry B Gristick, Louise Scharf, Anthony P West Jr, Rachel P Galimidi, Michael S Seaman, Natalia T Freund, Michel C Nussenzweig, Pamela J Bjorkman

Get full text

Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration by Vaneet K. Sharma, Bijay Misra, Kevin T. McManus, Sreenivas Avula, Kaliappanadar Nellaiappan, Marina Caskey, Jill Horowitz, Michel C. Nussenzweig, Michael S. Seaman, Indu Javeri, Antu K. Dey

Get full text

Different pattern of immunoglobulin gene usage by HIV-1 compared to non-HIV-1 antibodies derived from the same infected subject. by Liuzhe Li, Xiao-Hong Wang, Sagarika Banerjee, Barbara Volsky, Constance Williams, Diana Virland, Arthur Nadas, Michael S Seaman, Xuemin Chen, Paul Spearman, Susan Zolla-Pazner, Miroslaw K Gorny

Get full text

Contribution of intrinsic reactivity of the HIV-1 envelope glycoproteins to CD4-independent infection and global inhibitor sensitivity. by Hillel Haim, Bettina Strack, Aemro Kassa, Navid Madani, Liping Wang, Joel R Courter, Amy Princiotto, Kathleen McGee, Beatriz Pacheco, Michael S Seaman, Amos B Smith, Joseph Sodroski

Get full text

Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility by Kemin Tan, Junjian Chen, Yu Kaku, Yi Wang, Luke Donius, Rafiq Ahmad Khan, Xiaolong Li, Hannah Richter, Michael S. Seaman, Thomas Walz, Wonmuk Hwang, Ellis L. Reinherz, Mikyung Kim

Get full text

Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity by Julie Prigent, Annaëlle Jarossay, Cyril Planchais, Caroline Eden, Jérémy Dufloo, Ayrin Kök, Valérie Lorin, Oxana Vratskikh, Thérèse Couderc, Timothée Bruel, Olivier Schwartz, Michael S. Seaman, Oliver Ohlenschläger, Jordan D. Dimitrov, Hugo Mouquet

Get full text

Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike by Louise Scharf, Johannes F. Scheid, Jeong Hyun Lee, Anthony P. West Jr., Courtney Chen, Han Gao, Priyanthi N.P. Gnanapragasam, René Mares, Michael S. Seaman, Andrew B. Ward, Michel C. Nussenzweig, Pamela J. Bjorkman

Get full text

Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope by Morgan E. Abernathy, Harry B. Gristick, Jost Vielmetter, Jennifer R. Keeffe, Priyanthi N. P. Gnanapragasam, Yu E. Lee, Amelia Escolano, Rajeev Gautam, Michael S. Seaman, Malcolm A. Martin, Michel C. Nussenzweig, Pamela J. Bjorkman

Get full text

Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections. by Kshitij Wagh, Michael S Seaman, Marshall Zingg, Tomas Fitzsimons, Dan H Barouch, Dennis R Burton, Mark Connors, David D Ho, John R Mascola, Michel C Nussenzweig, Jeffrey Ravetch, Rajeev Gautam, Malcolm A Martin, David C Montefiori, Bette Korber

Get full text